BEUDAMED
    FDA Adverse Event Injury Summary report: N

    INTRALASE FS2

    MDR report key: 3914883 · Received July 4, 2014

    Report

    Report Number
    3006695864-2014-00321
    Event Type
    Injury
    Date Received
    July 4, 2014
    Date of Event
    June 6, 2014
    Report Date
    June 7, 2014
    Manufacturer
    ABBOTT MEDICAL OPTICS
    Product Code
    HNO
    PMA / PMN Number
    K060372
    Adverse Event
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    PA, US
    Reporter Occupation
    PHYSICIAN

    Narratives

    Additional Manufacturer Narrative · 1

    (B)(4). THE CLINIC IS REPORTING THIS ADVERSE EVENT ONLY AND DID NOT REQUEST OR REQUIRE FIELD SERVICE OR CLINICAL SUPPORT. ALL PERTINENT INFORMATION AVAILABLE TO ABBOTT MEDICAL OPTICS HAS BEEN SUBMITTED. PLACEHOLDER.

    Description of Event or Problem · 1

    THE CLINIC REPORTED THAT A LASER VISION CORRECTION PATIENT PRESENTED WITH IRREGULAR ABLATION AND POSSIBLE ANTERIOR BASEMENT MEMBRANE CORNEAL DYSTROPHY (AMBD) IN RIGHT EYE ONE WEEK POST TREATMENT. THE TOPICAL STEROID DOSAGE WAS INCREASED. IT WAS STATED THAT THE PATIENT EXPERIENCED LOSS OF BEST CORRECTED VISUAL ACUITY (BCVA). THE PATIENT COMPLAINED OF BLURRY VISUAL ACUITY IN RIGHT EYE AND REPORTED THAT VISUAL ACUITY HAS STEADILY DECLINED IN PAST 2 DAYS. BCVA RIGHT EYE PRE-OP 20/20 POST-OP 20/25. BCVA LEFT EYE PRE-OP 20/20 POST-OP 20/30.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    392842 INTRALASE FS2 FEMTOSECOND LASER HNO ABBOTT MEDICAL OPTICS 20003D

    Patients

    Seq Age Sex Outcome Treatment
    1 36 YR Other WAVELIGHT 1010-3-139